26 jul: Ambuja Cements Tops Forecast With 35% Jump in 2Q Net Profit
26 jul: OIL DATA: India June Crude-Oil Imports Fall 1.9% on Year to 13.67..
26-07-2012 11:57:00

UPDATE: Siemens Warns On Guidance; Shelves Osram IPO Plans

Relateret indhold

-Siemens shelves IPO plans for Osram, to spin off unit to shareholders instead

-Says difficult to reach EUR5.2 billion to EUR5.4 billion profit target due to economic challenges

-Warns demand from China won't pick up till 2013

(Adds details)

By Friedrich Geiger and Harriet Torry

MUNICH--German industrial conglomerate Siemens AG (SI) Thursday shelved plans to float its Osram lighting unit on the stock market and warned its full-year profit target is becoming more difficult to reach as third-quarter order intake fell sharply.

The company has been targeting profit of EUR5.2 billion to EUR5.4 billion for the year.

"We see growing reluctance among our customers regarding capital expenditures and stronger economic headwinds," said Chief Executive Peter Loescher.

The company's net profit, at 823 million euros ($996 million), was sharply below analysts' EUR1.32 billion consensus estimates due to an EUR351 million accounting charge related to a change in status of its lighting unit Osram which had been earmarked for an initial public offering.

Siemens warned demand from China is slowing and said it doesn't expect any recovery until next year. The company's focus now is on increasing productivity and efficiency as customers become more reluctant to spend. It said it will provide more details when it releases fourth-quarter results.

Siemens' guidance stands in contrast to that of industrial group ABB Ltd. (ABBN.VX), which on Thursday said it's more confident of its short-term outlook, and sees some signs of recovery in its China business.

"The macroeconomic view remains uncertain, but the positive developments we've seen in China, the continued strength of the U.S. market and our resilience in Europe make us more confident about the short-term outlook than we were three months ago,"said ABB Chief Executive Joe Hogan.

Developments are uneven, however, with another German heavyweight, chemicals group BASF SE (BAS.XE), Thursday noting slowing growth in China in the past quarter. BASF said it can't estimate when business in Asia will pick up again.

Siemens CEO Mr. Loescher said market conditions continue to be too volatile for an IPO of its Osram lighting unit, and it will now most likely spin off Osram to shareholders. Siemens aims to keep a minority stake in Osram, and the move will require shareholder approval at the next annual general meeting in January.

Analysts at Silvia Quandt Research said they expects Siemens to experience difficult quarters ahead, as the business climate seems to be deteriorating more than expected.

At 0916 GMT, Siemens shares traded down 4% at EUR64.61, while Germany's DAX index traded down 1.1%.

-Write to Friedrich Geiger at friedrich.geiger@dowjones.com

Harriet Torry also contributed to this article

Order free Annual Report for Siemens AG

Visit http://djnweurope.ar.wilink.com/?ticker=DE0007236101 or call +44 (0)208 391 6028

Order free Annual Report for BASF SE

Visit http://djnweurope.ar.wilink.com/?ticker=DE000BASF111 or call +44 (0)208 391 6028

Order free Annual Report for BASF SE

Visit http://djnweurope.ar.wilink.com/?ticker=US0552625057 or call +44 (0)208 391 6028

Order free Annual Report for Siemens AG

Visit http://djnweurope.ar.wilink.com/?ticker=US8261975010 or call +44 (0)208 391 6028

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 26, 2012 05:57 ET (09:57 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Maersk Line-chef tager på charmeoffensiv i Kina

19-09-2014 15:47:03
Den administrerende direktør for Maersk Line, Søren Skou, har besøgt de kinesiske myndigheder i et forsøg på at skaffe opbakning til en ny shipping-alliance med..

Novo/Sydbank: Novo sidder tungt på diabetes-tronen

19-09-2014 12:17:21
Sydbank fastholder sin anbefaling af Novo Nordisk-aktien til trods for, at den amerikanske lægemiddelstyrelse, FDA, torsdag aften har godkendt Novo-konkurrenten..

Novo: Nygodkendt diabetesmiddel giver lynhurtigt effekt

19-09-2014 11:31:02
Novo Nordisks nye kombinationspræparat til behandling af type 2 diabetes, Xultophy, yder allerede efter fire uger en betydelig blodsukkerkontrol.Det fremgår af ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

ABB Ltd N 21,66 0,6% Stigning i aktiekurs
ABB Ltd 23,00 -0,4% Fald i aktiekurs
ABB Ltd 164,40 0,3% Stigning i aktiekurs
Siemens AG Siemens ORD S.. 98,68 1,4% Stigning i aktiekurs
Basf SE Basf SE REG SHS 77,21 1,1% Stigning i aktiekurs
Basf N 93,55 1,2% Stigning i aktiekurs
Siemens 98,25 0,8% Stigning i aktiekurs
Siemens N 118,30 0,8% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen
Køb

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
21. september 2014 22:10:52
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140919.1 - EUROWEB7 - 2014-09-21 22:10:52 - 2014-09-21 22:10:52 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x